# MR-linac Guided Adaptive Radiotherapy for Inoperable Mediastinal Tumor

> **NCT05163509** · PHASE2 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 59 (estimated)

## Conditions studied

- Mediastinal Tumor

## Interventions

- **COMBINATION_PRODUCT:** Unity-based MR-Linac guided Radiotherapy

## Key facts

- **NCT ID:** NCT05163509
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-01
- **Primary completion:** 2023-10-01
- **Final completion:** 2023-10-01
- **Target enrollment:** 59 (ESTIMATED)
- **Last updated:** 2021-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05163509

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05163509, "MR-linac Guided Adaptive Radiotherapy for Inoperable Mediastinal Tumor". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05163509. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*